Pegvisomant
- Generic Name
- Pegvisomant
- Brand Names
- Somavert
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 218620-50-9
- Unique Ingredient Identifier
- N824AOU5XV
- Background
Pegvisomant is a highly selective growth hormone (GH) receptor antagonist. It is used to treat acromegaly. Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main mediator of growth hormone activity.
- Indication
Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.
- Associated Conditions
- Acromegaly
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath